Alembic Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹1,678.45Cr |
Net Profits | ₹153.41Cr |
Net Profit Margins | 9.14% |
Highlights
Revenue:
Alembic Pharmaceuticals Ltd’s revenue jumped 4.57% since last year same period to ₹1,678.45Cr in the Q2 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 7.31% jump in its revenue since last 3-months.
Net Profits:
Alembic Pharmaceuticals Ltd’s net profit jumped 12.34% since last year same period to ₹153.41Cr in the Q2 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 13.88% jump in its net profits since last 3-months.
Net Profit Margins:
Alembic Pharmaceuticals Ltd’s net profit margin jumped 7.43% since last year same period to 9.14% in the Q2 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 6.13% jump in its net profit margins since last 3-months.
